HomeNews

News

Opdivo Plus Yervoy Might Enhance Survival and Responses in Frontline uHCC

Opdivo plus Yervoy considerably improved general survival and response charges in comparison with Lenvima or Nexavar as first-line therapy for unresectable hepatocellular carcinoma.Amongst...

Aspirin Could Scale back Recurrence in PI3K-mutated Colorectal Most cancers

Aspirin use diminished the danger of colorectal most cancers recurrence by 50% in sufferers with mutations within the PI3K signaling pathway.Amongst sufferers with...

Do Vaginal Rashes or Infections Have Any Reference to Cervical Most cancers?

Vaginal rashes or infections, like yeast infections or bacterial vaginitis, are typically unrelated to cervical most cancers. Nonetheless, power infections attributable to high-risk...

Opdivo Routine Could Extend Survival in Chinese language Sufferers With Sure GI Cancers

Opdivo and chemo confirmed long-term survival in superior gastric, gastroesophageal junction or esophageal most cancers.Chinese language sufferers with superior gastric most cancers, gastroesophageal...

FDA Approves GRAFAPEX/Fludarabine Earlier than alloHSCT in AML and MDS

The FDA authorised GRAFAPEX and fludarabine as a preparative routine in acute myeloid leukemia or myelodysplastic syndrome previous to alloHSCT.The Meals and Drug...

Hot Topics